Real-world characteristics, treatment patterns, and outcomes in advanced HER2 (ERBB2)-mutant non-small cell lung cancer: a retrospective study of single centers in France and Germany
Purpose - Human epidermal growth factor receptor 2 (HER2 [ERBB2]) gene mutations occur in ∼3-5% of non-small cell lung cancer (NSCLC) cases and are associated with poor prognosis. However, real-world data on patients with HER2-mutant (HER2m) NSCLC are needed. - Methods - This retrospective, observat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 2025
|
| In: |
Clinical therapeutics
Year: 2025, Jahrgang: 47, Heft: 12, Pages: 1161-1169 |
| ISSN: | 1879-114X |
| DOI: | 10.1016/j.clinthera.2025.09.019 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.clinthera.2025.09.019 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0149291825003455 |
| Verfasserangaben: | Petros Christopoulos, Christin Assmann, Lirong Zhang, Kyle Dunton, Ahmed Ali, Mehmet Berktas, Lisa Delmastro, Alessandria Strübing, Yan Xiong, Sarah Lay-Flurrie, Pooja Hindocha, Tarana Mehdikhanova, Nicolas Girard |
Search Result 1
Search Result 2